The FTSE 100 look set to open firmly in positive territory, buoyed by the showing of Asia’s main markets, which in turn were supported by vaccine and stimulus optimism.
Japan’s Nikkei stood out as it pushed through 30,000 for the first time in 31 years; however, it was reflective of a region where bourses are bubbling along near peak levels.
With the sideshow of Donald Trump’s impeachment now over, newly elected President Biden is expected to turn his full attention to the economic bail-out package for the world’s largest economy.
Anything less than the well-trailed US$1.9bn injection is likely at this stage to be seen as disappointing.
Elsewhere, the UK appears to be at the vanguard of something other than Covid infections having inoculated 15mln people, or just over a fifth of the population.
The national press this morning was cautiously optimistic about a staged return to normality in the spring.
The Daily Mail said: “There could be light at the end of the tunnel as ministers discuss plans to allow for shops to re-open, families to be re-united and self-catering staycations to be given the go ahead if COVID-19 infection rates continue to plummet amid the vaccine rollout.”
Expect the oil stocks to be marked up with crude prices up around 2% in early Monday trading amid heightened tensions on the Arabian peninsular.
Reuters said the Saudi-led coalition fighting in Yemen intercepted and destroyed an explosive-laden drone that was believed to be fired by the Iran-aligned Houthi group toward the kingdom, state TV reported, raising fears of fresh Middle East tensions.
Looking ahead, the week appears to be a fairly busy one for corporate news with updates mainly from banks and miners.
- Pound US$1.3897 (+0.35%)
- Bitcoin US$47,070.37 (-4.38%)
- Gold US$1,824.30 (+0.1%)
- Brent crude US$63.65 (+1.95%)
6.50am: Early Markets – Asia / Australia
Major stock markets in the Asia-Pacific region were higher on Monday as Japan’s Nikkei 225 surged past the 30,000 level for the first time in more than 30 years.
South Korea’s Kospi jumped 1.5% while the S&P/ASX 200 in Australia closed 0.91% higher.
In Japan, the Nikkei 225 surged 1.91% to 30,084 points.
Markets in China, Hong Kong, Taiwan as well as the U.S. are closed on Monday for holidays.
Proactive Australia news:
Maximus Resources Limited’s (ASX:MXR) (FRA:M5F) ongoing diamond drilling has returned up to 48.4 g/t gold and extended mineralisation at Redback Gold Deposit within its Spargoville tenements, around 24 kilometres from Kambalda in Western Australia’s premier gold and nickel mining district.
Creso Pharma Ltd (ASX:CPH) (FRA:1X8) (OTCMKTS:COPHF) has secured a comprehensive distribution agreement with leading nutritional supplements company, Route2 Pharm Pvt Ltd for its hemp-derived therapeutic products exclusively into Pakistan and Philippines, and non-exclusively into other potential target markets.
MGC Pharmaceuticals Ltd’s (ASX:MXC) (LON:MXC) (OTCMKTS:MGCLF) ongoing pre-clinical research program into the use of cannabinoids in the treatment of aggressive glioblastoma brain cancer has been expanded to explore the use of nanotechnology in relation to the most effective treatment delivery systems.
Queensland Pacific Metals Ltd’s (ASX:QPM) (FRA:4EA) pilot plant test-work has confirmed the flowsheet, providing confidence to proceed towards a definitive feasibility study for the Townsville Energy Chemicals Hub (TECH) Project in North Queensland.
Ora Banda Mining Ora Ltd (ASX:OBM) (FRA:M6N) has signed a A$15 million credit approved offer with the Commonwealth Bank of Australia (ASX:CBA) (OTCMKTS:CBAUF) (FRA:CWW) for hedging and working capital purposes to support prudent risk and capital management during the ramp-up phase, subsequent to the first gold pour at Davyhurst on February 7, 2021.
Orthocell Ltd (ASX:OCC) has received a new US divisional patent for CelGro® that covers the method of manufacture of collagen medical devices and as an aid in the surgical repair of soft tissue injuries.